Last updated on February 2019

A Study Comparing the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Chronic Cluster Headache (CCH)


Contact Investigators or Research Sites near you

Start Over

Teva U.S. Medical Information

Teva Investigational Site 40030
Helsinki, Finland

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.